Patent ID: 9408835
Filing Date: 2016-08-09
CPC Classification: A61K,A61P

Claim Text:
1. A tablet for oral administration, comprising 4-{[(1R,2s,3S,5s,7s)-5-hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide or a pharmaceutically acceptable salt thereof, and a hydrophilic lubricant, wherein the hydrophilic lubricant is one, or two or more selected from the group consisting of sodium stearyl fumarate, polyethylene glycol, and sodium lauryl sulfate, wherein the content of 4-{[(1R,2s,3S,5s,7s)-5-hydroxy-2-adamantyl]amino}-1H-pyrrolo[2,3-b]pyridine-5-carboxamide or a pharmaceutically acceptable salt thereof to the tablet for oral administration is about 30% by weight to about 60% by weight, wherein the content of the hydrophilic lubricant to the tablet for oral administration is 1% by weight to 10% by weight, and a hydrophilic substance wherein the hydrophilic substance is a sugar alcohol.